19520558|t|Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection.
19520558|a|Deficiency in docosahexaenoic acid (DHA) is associated with impaired visual and neurological postnatal development, cognitive decline, macular degeneration, and other neurodegenerative diseases. DHA is an omega-3 polyunsaturated fatty acyl chain concentrated in phospholipids of brain and retina, with photoreceptor cells displaying the highest content of DHA of all cell membranes. The identification and characterization of neuroprotectin D1 (NPD1, 10R, 17S-dihydroxy-docosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid) contributes in understanding the biological significance of DHA. In oxidative stress-challenged human retinal pigment epithelial (RPE) cells, human brain cells, or rat brains undergoing ischemia-reperfusion, NPD1 synthesis is enhanced as a response for sustaining homeostasis. Thus, neurotrophins, Abeta peptide 42 (Abeta42), calcium ionophore A23187, interleukin (IL)-1beta, or DHA supply enhances NPD1 synthesis. NPD1, in turn, up-regulates the antiapoptotic proteins of the Bcl-2 family and decreases the expression of proapoptotic Bcl-2 family members. Moreover, NPD1 inhibits IL-1beta-stimulated expression of cyclooxygenase-2 (COX-2). Because both RPE and photoreceptors are damaged and then die in retinal degenerations, elucidating how NPD1 signaling contributes to retinal cell survival may lead to a new understanding of disease mechanisms. In human neural cells, DHA attenuates amyloid-beta (Abeta) secretion, resulting in concomitant formation of NPD1. NPD1 was found to be reduced in the Alzheimer's disease (AD) cornu ammonis region 1 (CA1) hippocampal region, but not in other areas of the brain. The expression of key enzymes for NPD1 biosynthesis, cytosolic phospholipase A(2) (cPLA(2)), and 15-lipoxygenase (15-LOX) was found altered in the AD hippocampal CA1 region. NPD1 repressed Abeta42-triggered activation of pro-inflammatory genes and upregulated the antiapoptotic genes encoding Bcl-2, Bcl-xl, and Bfl-1(A1) in human brain cells in culture. Overall, these results support the concept that NPD1 promotes brain and retina cell survival via the induction of antiapoptotic and neuroprotective gene-expression programs that suppress Abeta42-induced neurotoxicity and other forms of cell injury, which in turn fosters homeostasis during development in aging, as well as during the initiation and progression of neurodegenerative diseases.
19520558	42	62	docosahexaenoic acid	Chemical	MESH:D004281
19520558	166	186	docosahexaenoic acid	Chemical	MESH:D004281
19520558	188	191	DHA	Chemical	MESH:D004281
19520558	212	266	impaired visual and neurological postnatal development	Disease	MESH:D014786
19520558	268	285	cognitive decline	Disease	MESH:D003072
19520558	319	345	neurodegenerative diseases	Disease	MESH:D019636
19520558	347	350	DHA	Chemical	MESH:D004281
19520558	357	397	omega-3 polyunsaturated fatty acyl chain	Chemical	-
19520558	414	427	phospholipids	Chemical	MESH:D010743
19520558	508	511	DHA	Chemical	MESH:D004281
19520558	603	665	10R, 17S-dihydroxy-docosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid	Chemical	MESH:C487679
19520558	727	730	DHA	Chemical	MESH:D004281
19520558	763	768	human	Species	9606
19520558	769	784	retinal pigment	CellLine	CVCL:IQ82
19520558	797	800	RPE	CellLine	CVCL:0145
19520558	809	814	human	Species	9606
19520558	831	834	rat	Species	10116
19520558	853	861	ischemia	Disease	MESH:D007511
19520558	983	990	Abeta42	Gene	351
19520558	993	1000	calcium	Chemical	MESH:D002118
19520558	1011	1017	A23187	Chemical	MESH:D000001
19520558	1019	1041	interleukin (IL)-1beta	Gene	3553
19520558	1046	1049	DHA	Chemical	MESH:D004281
19520558	1144	1149	Bcl-2	Gene	596
19520558	1202	1207	Bcl-2	Gene	596
19520558	1248	1256	IL-1beta	Gene	3553
19520558	1282	1298	cyclooxygenase-2	Gene	5743
19520558	1300	1305	COX-2	Gene	5743
19520558	1321	1324	RPE	CellLine	CVCL:0145
19520558	1372	1393	retinal degenerations	Disease	MESH:D012162
19520558	1521	1526	human	Species	9606
19520558	1541	1544	DHA	Chemical	MESH:D004281
19520558	1556	1568	amyloid-beta	Gene	351
19520558	1570	1575	Abeta	Gene	351
19520558	1668	1687	Alzheimer's disease	Disease	MESH:D000544
19520558	1689	1691	AD	Disease	MESH:D000544
19520558	1832	1860	cytosolic phospholipase A(2)	Gene	5321
19520558	1862	1869	cPLA(2)	Gene	5321
19520558	1876	1891	15-lipoxygenase	Gene	246
19520558	1893	1899	15-LOX	Gene	246
19520558	1926	1928	AD	Disease	MESH:D000544
19520558	1968	1975	Abeta42	Gene	351
19520558	2004	2016	inflammatory	Disease	MESH:D007249
19520558	2072	2077	Bcl-2	Gene	596
19520558	2079	2085	Bcl-xl	Gene	598
19520558	2104	2109	human	Species	9606
19520558	2321	2328	Abeta42	Gene	351
19520558	2337	2350	neurotoxicity	Disease	MESH:D020258
19520558	2498	2524	neurodegenerative diseases	Disease	MESH:D019636
19520558	Negative_Correlation	MESH:D004281	351
19520558	Negative_Correlation	MESH:D004281	MESH:D019636
19520558	Negative_Correlation	MESH:D004281	MESH:D003072
19520558	Positive_Correlation	MESH:D007249	351
19520558	Association	MESH:D004281	246
19520558	Negative_Correlation	MESH:D004281	MESH:D014786
19520558	Association	MESH:D000544	246
19520558	Association	MESH:D000544	5321
19520558	Positive_Correlation	3553	5743

